Antimicrobial Resistance and Novel Alternative Approaches to Conventional Antibiotics
Bacteria · 22.07.2024 · 3 (3) · 171-182
DOI: 10.3390/bacteria3030012 ↗Kurz gefasst
Fachartikel in der Zeitschrift Bacteria, online erschienen am 22.07.2024. Verfasst von Irene Berger und 1 weiteren Autor:innen. Die Arbeit wurde bisher 46-mal zitiert (Crossref) und nennt 52 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Antimicrobial resistance is a significant public health issue. The unprecedented spread of antimicrobial-resistant organisms has been identified by the World Health Organization as one of the leading healthcare threats. Projections for annual worldwide deaths attributed to antimicrobial resistance approach 10 million by 2050, with an associated economic burden of USD 100 trillion. This paper reviews the mechanisms known to contribute to antimicrobial resistance and provides insight into potential available alternatives to conventional antibiotics. Antimicrobial approaches addressed include dual antibiotic therapy, antimicrobial peptides, monoclonal antibodies, bacteriophages, probiotics, nanomaterials, and cannabinoids. Key pathogens in need of antimicrobials referred to as the ESKAPE pathogens are discussed.
Zitieren
APA
Berger, I., & Loewy, Z. G. (2024). Antimicrobial Resistance and Novel Alternative Approaches to Conventional Antibiotics. Bacteria, 3(3), 171-182. https://doi.org/10.3390/bacteria3030012
Vancouver
Berger I, Loewy ZG. Antimicrobial Resistance and Novel Alternative Approaches to Conventional Antibiotics. Bacteria. 2024;3(3):171-182. doi:10.3390/bacteria3030012
BibTeX
@article{Berger2024,
author = {Berger, Irene and Loewy, Zvi G.},
title = {Antimicrobial Resistance and Novel Alternative Approaches to Conventional Antibiotics},
journal = {Bacteria},
year = {2024},
volume = {3},
number = {3},
pages = {171--182},
doi = {10.3390/bacteria3030012}
}
EUVIMED